Patents by Inventor Char-Huei Lai

Char-Huei Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070066813
    Abstract: Modified fusion proteins of transferrin and therapeutic proteins or peptides including soluble toxin receptors, with increased serum half-life or serum stability are disclosed. Preferred fusion proteins include those modified so that the transferrin moiety exhibits no or reduced glycosylation, binding to iron and/or binding to the transferrin receptor.
    Type: Application
    Filed: August 28, 2003
    Publication date: March 22, 2007
    Inventors: Christopher Prior, Char-Huei Lai, Homayoun Sadeghi, Andrew Turner
  • Publication number: 20070050855
    Abstract: Modified fusion proteins of transferrin and therapeutic proteins or peptides including soluble toxin receptors, with increased serum half-life or serum stability are disclosed. Preferred fusion proteins include those modified so that the transferrin moiety exhibits no or reduced glycosylation, binding to iron and/or binding to the transferrin receptor.
    Type: Application
    Filed: August 15, 2006
    Publication date: March 1, 2007
    Inventors: Christopher Prior, Char-Huei Lai, Homayoun Sadeghi, Andrew Turner
  • Publication number: 20030221201
    Abstract: Modified fusion proteins of transferrin and therapeutic proteins or peptides including soluble toxin receptors, with increased serum half-life or serum stability are disclosed. Preferred fusion proteins include those modified so that the transferrin moiety exhibits no or reduced glycosylation, binding to iron and/or binding to the transferrin receptor.
    Type: Application
    Filed: March 4, 2003
    Publication date: November 27, 2003
    Applicant: BIOREXIS PHARMACEUTICAL CORPORATION
    Inventors: Christopher P. Prior, Char-Huei Lai, Homayoun Sadeghi, Andrew Turner